title: Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.
authors.forename: Carmen
authors.initials: C
authors.lastname: Baldazzi
authors.forename: Simona
authors.initials: S
authors.lastname: Luatti
authors.forename: Giulia
authors.initials: G
authors.lastname: Marzocchi
authors.forename: Monica
authors.initials: M
authors.lastname: Stacchini
authors.forename: Carla
authors.initials: C
authors.lastname: Gamberini
authors.forename: Fausto
authors.initials: F
authors.lastname: Castagnetti
authors.forename: Francesca
authors.initials: F
authors.lastname: Palandri
authors.forename: Gianantonio
authors.initials: G
authors.lastname: Rosti
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Testoni
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002869:Chromosome Aberrations; D005260:Female; D006410:Hematopoiesis / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; C498826:nilotinib